Skip to content
Unither

Unither

Pharma·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Unither?

Unither is currently owned by Parquest Capital through Parquest Capital 2 (2017 vintage), since 2022. Across its history, Unither has been through 4 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Parquest Capital
Most recent investor
Parquest Capital
Parquest Capital 2 · 2017 · Buyout
5 ownership periods · full history below

Key facts

HQFrance
SectorPharma
Key takeaways
  • ·Co-held by Picardie Investissement Gestion, NiXEN and Parquest Capital since 1993.
  • ·Average hold across 2 realized cycles: 6 years.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

5 ownership periods · co-invest detected

Active
Co-invest · 5 holders · 1993 · present
Picardie Investissement Gestion
1993 · present(33yr) · Picardie Investissement · 1991 · Evergreen
NiXEN
NiXENExited 2019
2014 · 2019(5yr) · NiXEN II · 2012 · Buyout
Trade Sale
MOIC
Ardian
ArdianExited 2023
2017 · 2023(6yr) · Ardian Buyout Fund VII · 2017 · Buyout
Secondary · to
MOIC
Parquest Capital
2022 · present(4yr) · Parquest Capital 2 · 2017 · Buyout
NiXEN
NiXENActive
2022 · present(4yr) · NiXEN II · 2012 · Buyout
Track Unither

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Unither?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Unither.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue